IMTX
Price
$4.50
Change
-$0.16 (-3.43%)
Updated
Mar 10 closing price
Capitalization
566.42M
8 days until earnings call
ROIV
Price
$10.59
Change
-$0.05 (-0.47%)
Updated
Mar 10, 04:59 PM (EDT)
Capitalization
7.59B
106 days until earnings call
Ad is loading...

IMTX vs ROIV

Header iconIMTX vs ROIV Comparison
Open Charts IMTX vs ROIVBanner chart's image
Immatics
Price$4.50
Change-$0.16 (-3.43%)
Volume$333.08K
Capitalization566.42M
Roivant Sciences
Price$10.59
Change-$0.05 (-0.47%)
Volume$85K
Capitalization7.59B
IMTX vs ROIV Comparison Chart
Loading...
IMTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ROIV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMTX vs. ROIV commentary
Mar 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMTX is a StrongBuy and ROIV is a Hold.

Ad is loading...
COMPARISON
Comparison
Mar 11, 2025
Stock price -- (IMTX: $4.50 vs. ROIV: $10.58)
Brand notoriety: IMTX and ROIV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMTX: 32% vs. ROIV: 117%
Market capitalization -- IMTX: $566.42M vs. ROIV: $7.59B
IMTX [@Biotechnology] is valued at $566.42M. ROIV’s [@Biotechnology] market capitalization is $7.59B. The market cap for tickers in the [@Biotechnology] industry ranges from $383.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMTX’s FA Score shows that 0 FA rating(s) are green whileROIV’s FA Score has 1 green FA rating(s).

  • IMTX’s FA Score: 0 green, 5 red.
  • ROIV’s FA Score: 1 green, 4 red.
According to our system of comparison, ROIV is a better buy in the long-term than IMTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMTX’s TA Score shows that 4 TA indicator(s) are bullish while ROIV’s TA Score has 4 bullish TA indicator(s).

  • IMTX’s TA Score: 4 bullish, 4 bearish.
  • ROIV’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, ROIV is a better buy in the short-term than IMTX.

Price Growth

IMTX (@Biotechnology) experienced а +7.66% price change this week, while ROIV (@Biotechnology) price change was +4.03% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.04%. For the same industry, the average monthly price growth was -8.82%, and the average quarterly price growth was -8.10%.

Reported Earning Dates

IMTX is expected to report earnings on May 20, 2025.

ROIV is expected to report earnings on Jun 25, 2025.

Industries' Descriptions

@Biotechnology (-0.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ROIV($7.59B) has a higher market cap than IMTX($566M). ROIV YTD gains are higher at: -10.059 vs. IMTX (-36.709). ROIV has higher annual earnings (EBITDA): 4.15B vs. IMTX (-36.26M). ROIV has more cash in the bank: 5.39B vs. IMTX (491M). IMTX has less debt than ROIV: IMTX (16M) vs ROIV (52.7M). ROIV has higher revenues than IMTX: ROIV (129M) vs IMTX (116M).
IMTXROIVIMTX / ROIV
Capitalization566M7.59B7%
EBITDA-36.26M4.15B-1%
Gain YTD-36.709-10.059365%
P/E RatioN/A1.97-
Revenue116M129M90%
Total Cash491M5.39B9%
Total Debt16M52.7M30%
FUNDAMENTALS RATINGS
IMTX: Fundamental Ratings
IMTX
OUTLOOK RATING
1..100
11
VALUATION
overvalued / fair valued / undervalued
1..100
59
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
89
PRICE GROWTH RATING
1..100
89
P/E GROWTH RATING
1..100
94
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IMTXROIV
RSI
ODDS (%)
Bullish Trend 1 day ago
86%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 4 days ago
69%
Momentum
ODDS (%)
Bearish Trend 1 day ago
77%
Bearish Trend 4 days ago
71%
MACD
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 4 days ago
64%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 4 days ago
71%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
78%
Bearish Trend 4 days ago
69%
Advances
ODDS (%)
Bullish Trend 6 days ago
77%
Bullish Trend 6 days ago
70%
Declines
ODDS (%)
Bearish Trend 1 day ago
79%
Bearish Trend 14 days ago
73%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 4 days ago
72%
Aroon
ODDS (%)
Bearish Trend 1 day ago
83%
N/A
View a ticker or compare two or three
Ad is loading...
IMTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ROIV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
CEFA32.720.25
+0.77%
Global X S&P Cthlc Vls Dvlpd ex-US ETF
AVUS94.830.49
+0.52%
Avantis US Equity ETF
EMC26.580.13
+0.51%
Global X Emerging Mkts Great Cnsmr ETF
WDI14.54-0.06
-0.41%
Western Asset Diversified Income Fund
AMZY16.77-0.09
-0.53%
YieldMax AMZN Option Income Strategy ETF

IMTX and

Correlation & Price change

A.I.dvisor tells us that IMTX and INZY have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IMTX and INZY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMTX
1D Price
Change %
IMTX100%
-3.43%
INZY - IMTX
33%
Poorly correlated
-8.70%
ADMA - IMTX
33%
Poorly correlated
-2.41%
KRRO - IMTX
33%
Poorly correlated
-7.61%
VYGR - IMTX
32%
Poorly correlated
-2.11%
DNTH - IMTX
32%
Poorly correlated
+1.38%
More

ROIV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ROIV has been loosely correlated with IMVT. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if ROIV jumps, then IMVT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ROIV
1D Price
Change %
ROIV100%
+0.38%
IMVT - ROIV
52%
Loosely correlated
+2.56%
ACLX - ROIV
43%
Loosely correlated
+3.12%
AXON - ROIV
43%
Loosely correlated
+5.43%
DYN - ROIV
42%
Loosely correlated
+1.31%
KRYS - ROIV
42%
Loosely correlated
+0.56%
More